The reverse stock split is primarily intended to increase the Company's per share trading price and bring the Company into compliance with the Nasdaq's listing requirement regarding minimum share ...

The Reverse Split will legally take effect at 4:01 p.m. Eastern Time, on February 21, 2025. The Company’s common stock will open for trading under a new CUSIP number 3622AW 403 on The Nasdaq ...

60 Degrees Pharmaceuticals announces a 1-for-5 reverse stock split to comply with Nasdaq's minimum bid price requirement. 60 Degrees Pharmaceuticals, Inc. has announced a 1-for-5 reverse stock ...

BETHESDA, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the “Company”) (NASDAQ: HWH), a purpose-driven lifestyle company, today announced a 1-for-5 reverse stock split of the ...

The Reverse Stock Split is primarily intended to bring the Company into compliance with The Nasdaq Stock Market LLC’s (“Nasdaq”) $1.00 minimum bid price requirement for maintaining its ...

This reverse share split will reduce the number of common shares from approximately 64 million to about 2.1 million. The new shares are expected to trade on the Toronto Stock Exchange and NASDAQ ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new ...

GRI’s common stock is expected to begin trading on a post-split adjusted basis on February 24, 2025 LA JOLLA, CA, Feb. 19, ...

HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it will implement a 1-for-15 reverse stock split of the ...

Karyopharm (KPTI) will implement a 1-for-15 reverse stock split of the issued shares of the company’s common stock effective at 5:00 p.m.